PAMP
SRRA

Polar Asset Management Partners’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Polar Asset Management Partners’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-85,900
Closed -$1.87M – 1598
2021
Q4 		$1.87M Buy
+85,900
New +$1.89M 0.02% 621

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Polar Asset Management Partners's SRRA Position: Q1 2022 in Review

Polar Asset Management Partners sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2022, closing a stake of 85,900 shares — an estimated $1.87M sold.

Polar Asset Management Partners first reported a position in SRRA in Q4 2021 and held it in 1 quarter. The position peaked at $1.87M in Q4 2021. 75 funds tracked by Wall St. Rank hold SRRA as of Q1 2022.

  • Polar Asset Management Partners reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Polar Asset Management Partners sold 85,900 Sierra Oncology, Inc. Common Stock shares in Q1 2022, an estimated $1.87M.
  • Polar Asset Management Partners first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Polar Asset Management Partners's Sierra Oncology, Inc. Common Stock position peaked at $1.87M in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2022.

Based on Polar Asset Management Partners's 13F filing for Q1 2022, filed 16 May 2022.